Should all patients with coronary disease receive angiotensin-converting-enzyme inhibitors?
- 1 September 2003
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 362 (9386) , 755-757
- https://doi.org/10.1016/s0140-6736(03)14295-x
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Myocardial infarction redefined—A consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the Redefinition of Myocardial InfarctionEuropean Heart Journal, 2000
- Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patientsThe Lancet, 2000
- Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractionsThe Lancet, 1992
- Blood pressure, stroke, and coronary heart disease: Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution biasPublished by Elsevier ,1990